USANA Health Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a USNA research report →
Range $35 – $35
Price Chart
About the company
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer.
- CEO
- Kevin G. Guest
- IPO
- 1994
- Employees
- 1,570
- HQ
- Salt Lake City, UT, US
Get TickerSpark's AI analysis on USNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $242.05M
- P/E
- -10.86
- Fwd P/E
- 17.25
- PEG
- 0.06
- P/S
- 0.27
- P/B
- 0.46
- EV/EBITDA
- 2.25
- Div Yield
- 0.00%
- Gross Margin
- 77.45%
- Op Margin
- 1.35%
- Net Margin
- -2.43%
- ROE
- -4.16%
- ROIC
- -23.84%
Latest fiscal year · YoY change
- Revenue
- $925.26M+8.3%
- Gross Profit
- $724.40M+6.7%
- Op Income
- $50.86M
- Net Income
- $10.76M-74.4%
- EPS
- $0.58-73.6%
- OCF Growth
- -63.4%
- FCF Growth
- -83.3%
- 52W High
- $32.32
- 52W Low
- $12.57
- 50D MA
- $19.55
- 200D MA
- $19.46
- Beta
- 0.72
- RSI (14)
- 27
- Avg Volume
- 146.59K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
USANA reported a difficult quarter with a $29 million goodwill impairment and elevated tax expense, but management stayed constructive on core nutrition, China, and the long-term shift to a diversified omnichannel model.· August 5, 2026
- Core nutritional business was described as performing in line with expectations and gaining traction, with Greater China showing renewed strength.
- USANA took a preliminary noncash goodwill impairment charge of $29 million tied to HYA and recorded $9 million of income tax expense on a pretax loss of $19 million.
- HYA faced tougher and more expensive digital marketing conditions, with subscriber growth pressured by Meta-related customer acquisition issues.
- Rise Wellness was disrupted by a packaging issue; management said it is resolved, but full-year net sales are now expected to be lower than previously anticipated.
- Management emphasized continued investment in technology, innovation, retail expansion, and omnichannel capabilities, including Glow, TikTok, Target, Amazon, and new product launches.
Reported results included a preliminary noncash goodwill impairment charge of $29 million related to HYA and $9 million of income tax expense on a pretax loss of $19 million. Kevin Guest said USANA ended the quarter with $169 million in cash, zero debt, and generated $20 million of free cash flow, driven largely by working capital management. Management did not provide revenue or EPS figures in the prepared remarks read on this call. For fiscal 26, Doug Hekking said the company is lowering full-year outlook due to the more difficult and expensive direct-to-consumer digital marketing environment affecting HYA’s second-half net sales and lower near-term net sales from Rise Wellness; he also said the revised outlook implies about $30 million to $40 million of top-line pressure and roughly $4 million to $5 million of margin pressure from the Rise issue. He added the tax rate will remain elevated through the year.
Kevin Guest framed the quarter as evidence that USANA is evolving into a “diversified omnichannel health and wellness company,” with science, consumer loyalty, and multiple channels at the center of the strategy. He highlighted stability in core nutrition, improving momentum in Mainland China, the launch of Glow, and progress in HYA’s retail and international expansion. His tone was confident and forward-looking, while still acknowledging that some parts of the portfolio are facing near-term disruptions.
Doug Hekking focused on two main financial items: the $29 million preliminary goodwill impairment charge for HYA and the $9 million income tax expense on a pretax loss of $19 million. He said the impairment reflects lower-than-expected near-term performance and updated valuation assumptions, but not a change in commitment to the business. On guidance, he said the full-year outlook is being reduced because of HYA’s DTC marketing pressure and lower near-term Rise sales, while the core nutritional business remains largely in line with expectations. He also said the tax rate will be elevated through the year because of the near-term pressure in the venture businesses and the resulting mismatch between where revenue is generated and where costs are incurred.
Analysts pressed management on the sustainability of the China uptick, the weakness in North Asia, HYA’s direct subscription business, and whether the company is reducing reliance on Meta by shifting spend to TikTok and retail. Management said China’s improvement partly reflects momentum from earlier incentives and new product activity, plus stronger local leadership, and they expect continued progress. For HYA, management said Meta’s CAC and algorithm changes hurt customer acquisition, but recent months have improved and TikTok, retail, and international expansion are now key growth levers. On Rise Wellness, management said the packaging issue was cosmetic, not a safety issue, and noted that by year-end the brand should be in over 4,000 retail doors.
The positive case from this call is that USANA still sees traction in core nutrition, especially in Greater China, and management believes that market leadership there is stronger than ever. The company also pointed to multiple growth avenues—Glow, HYA retail and international expansion, TikTok, and Rise’s rapid door expansion—as evidence that the omnichannel strategy is starting to take shape.
The main risks are execution and near-term volatility in the venture businesses: HYA is facing a tougher digital ad environment and lower subscriber growth, while Rise Wellness had a packaging disruption that hurt the quarter and reduced full-year expectations. The goodwill impairment, elevated tax rate, and lowered outlook underscore that management’s newer growth initiatives are not yet producing consistent financial results.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 53.4%
- Shares Outstanding
- 18.46M
- Float Shares
- 9.87M
of shares held by institutions
140 13F filers
Buy/sell ratio 0.64. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.55M | ▲ 363.77K |
| Pzena Investment Management LLC | 1.21M | ▲ 96.65K |
| Renaissance Technologies LLC | 958.52K | ▼ 59.11K |
| Vanguard Group Inc | 934.32K | ▼ 134.72K |
| Dimensional Fund Advisors LP | 837.43K | ▲ 3.20K |
| Nantahala Capital Management, LLC | 810.07K | 0 |
| Vanguard Capital Management LLC | 487.37K | ▲ 8.33K |
| Creative Planning | 417.97K | ▲ 224.82K |
| Aqr Capital Management LLC | 408.09K | ▲ 111.67K |
| Geode Capital Management, LLC | 283.17K | ▲ 18.73K |
| Charles Schwab Investment Management Inc | 272.21K | ▼ 60.90K |
| Sixth Street Partners Management Company, L.P. | 272.21K | ▲ 272.21K |
Held by 154 ETFs
Biggest fund positions in USNA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 25, 26 | Benedict Peter | other | 598 |
| Jul 25, 26 | Benedict Peter | other | 598 |
| Jul 25, 26 | Benedict Peter | other | 176 |
| Jul 25, 26 | Armstrong Kathryn Michelle | other | 1,166 |
| Jul 25, 26 | Armstrong Kathryn Michelle | other | 1,166 |
| Jul 25, 26 | Armstrong Kathryn Michelle | other | 518 |
| Jul 23, 26 | WOOD TIMOTHY E | other | 1,632 |
| Jul 23, 26 | WOOD TIMOTHY E | other | 408 |
| Jul 23, 26 | WOOD TIMOTHY E | other | 1,632 |
| Jul 23, 26 | Winssinger Frederic J | other | 1,632 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our USNA coverage
Recent articles, reports, and earnings notes.
No research on USNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate USNA report →USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
prnewswire.com · Aug 17
Why Usana Health Sciences Stock Plummeted This Week
fool.com · Aug 9
USANA Health Sciences Q2 Earnings Call Highlights
marketbeat.com · Aug 9
USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)
seekingalpha.com · Aug 5
USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 5
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
prnewswire.com · Aug 5
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates
zacks.com · Aug 4
USANA Health Sciences Reports Second Quarter 2026 Results
businesswire.com · Aug 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.